MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dopamine"

  • 2019 International Congress

    Carrier Mediated Delivery System Bearing Dopamine for Effective Management of Parkinsonism

    M. Bhargava, S. Bhargava (Kanpur, India)

    Objective: In the present investigation, amino acid coupled liposomes bearing dopamine-HCl were prepared to deliver drug to the brain utilizing receptor-mediated transcytosis for effective management…
  • 2019 International Congress

    The contribution of striatal dopamine to feedforward motor control during gait initiation in Parkinson’s disease

    G. Brandt, C. Palmisano, J. Brumberg, N. Pozzi, A. Canessa, G. Pezzoli, I. Isaias, J. Volkmann (Würzburg, Germany)

    Objective: To establish the contribution of striatal dopamine to gait initiation in Parkinson’s disease. Background: Gait initiation (GI) is characterized by anticipatory postural adjustments (APAs),…
  • 2019 International Congress

    Memory enhancing effect of Combined Alcoholic Extract of Cedrus deodara Loud. and Vitex Nirgundi in scopolamine-induced cognitive impairment in mice

    A. Jain, S. Jain (Sagar, India)

    Objective: Epidemiological studies of Indian population reveal that dementia is largely a hidden problem in India. Ayurveda claims several plants are beneficial in cognitive disorders.…
  • 2019 International Congress

    Tissue Engineered Nigrostriatal Pathway as an Anatomically-Inspired Test-Bed for Evaluating Axonal Pathophysiology

    E. Clark, L. Struzyna, W. Gordian-Velez, I. Chen, J. Duda, D.K. Cullen (Philadelphia, PA, USA)

    Objective: We previously developed the first micro-tissue engineered nigrostriatal pathway encased in a tubular hydrogel with 3D structure, multicellular composition, and architecture of long axonal…
  • 2019 International Congress

    Dielectric Properties of a Blood Plasma Predict Motor Deficits in a 6-Hydroxydopamine-Induced Rat Model of Parkinson’s Disease

    E. Dalle, W. Daniels, M. Mabandla (Durban, South Africa)

    Objective: This study presents a novel method of predicting the behavioral pattern in male Sprague-Dawley rats with motor deficits impairment, based on the measurement of…
  • 2019 International Congress

    Glabellar tap predicts dopamine transporter deficiency in parkinsonism

    S. Nuuttila, J. Joutsa, M. Eklund, E. Jaakkola, E. Mäkinen, T. Noponen, T. Ihalainen, F. Scheperjans, V. Kaasinen (Turku, Finland)

    Objective: The objective of this study was to investigate the association between glabellar tap findings with nigrostriatal dopamine function in patients with unclear parkinsonism. Background:…
  • 2019 International Congress

    Comparison between [11C]PE2I PET and [123I]FP-CIT SPECT as markers of DAT expression in early Parkinson’s disease

    T. Yousaf, G. Pagano, H. Wilson, B. Corcoran, G. Vivian, M. Politis (London, United Kingdom)

    Objective: To compare single-photon emission computed tomography (SPECT) with [123I]FP-CIT and positron emission tomography (PET) with [11C]PE2I as markers of dopamine transporter (DAT) loss in…
  • 2019 International Congress

    Awareness of Levodopa/Carbidopa spacing with meals in patients of Idiopathic Parkinson’s disease – Insights from an Indian Parkinson’s Registry

    N. Sawal, K. Shukla (Chandigarh, India)

    Objective: Food interferes with gastrointestinal absorption of levodopa which requires spacing with meals. Study evaluated how many patient were spacing  levodopa correctly, its effect on…
  • 2019 International Congress

    Cognitive Inhibitory Control and Response to Dopaminergic Medication in Parkinson’s Disease

    M. El Haddouchi, A. Handberg, K. Svaerke, A. Loekkegaard (Copenhagen, Denmark)

    Objective: To investigate whether response to dopaminergic medication (DM) correlates to inhibitory cognitive control (IC) in patients with Parkinson's disease (PD). Background: In the MDS…
  • 2019 International Congress

    Neuroprotective effect of crocus sativus in lead-induced dopaminergic neurotoxicity in Meriones shawi: A possible link with Parkinson’s disease

    L. Tamegart, A. Abbaoui, R. Makbal, M. Zroudi, M. Bouyatas, B. Bouizgarne, H. Gamrani (Marrakesh, Morocco)

    Objective: In this study, we have evaluated, in one hand, the neurotoxic effect of Pb (25 mg / kg B.W i.p) for three consecutive days…
  • « Previous Page
  • 1
  • …
  • 9
  • 10
  • 11
  • 12
  • 13
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley